Patients with coeliac disease have IgM antibodies and IgA anti-gliadin antibody in gut secretions, and also high counts of intra-
epithelial lymphocytes (IEL) that express the y/6T celi receptor. These features of intestinal immunity may be markers of latent coeliac disease. Their occurrence was examined in 77 patients referred for jejunal biopsy, in whom biopsy histology was normal, to establish the extent to which these, and other candidate markers (high total IEL count, serum IgA antigliadin antibody (AGA), and increased permeability) coexist in the same patient. Twelve patients had high serum anti-gliadin antibody titres and nine increased permeability. The y/b IEL count was high (>5.5 per mm villus epithelium) in nine patients, the intestinal antibody pattern was positive in 21, and the total IEL count was high (>40 per 100 enterocytes) in antibody negative (p<0001); there were no other significant associations. Clinical tests of gluten sensitivity will be required to establish the prevalence of latent gluten sensitive enteropathy in the 40% of patients referred for jejunal biopsy in whom one or more of the immunological indices of potential coeliac disease is present. (Gut 1994; 35: 476-482) intestinal immune features may be candidate markers of latent or potential coeliac disease:
(1) High counts of T cell receptor y/6 intraepithelial lymphocytes (IEL) have been shown in dermatitis herpetiformis and in a case of latent coeliac disease34; (2) A coeliac-like intestinal antibody (CIA) pattern occurs in dermatitis herpetiformis patients with normal biopsy histology5; ( 3) The total IEL count may be high as a subtle feature of enteropathy in some coeliac disease patients6; (4) Anti-reticulin and anti-endomysium antibodies are present in some healthy relatives of coeliac disease patients7; (5) Intestinal permeability changes have also been reported in first degree relatives of coeliac disease patients.8
We recently reported that 19% of 217 noncoeliac disease patients referred for jejunal biopsy had a positive CIA pattern, and that a proportion of these (six of the nine patients who had a trial of gluten free diet) were clinically gluten sensitive, particularly when the total IEL count was high.9 We with a high count of y/b IEL are illustrated in the Figure. A Leitz-TAS plus computerised image analysis system (with a TASIC software operating system) was used for cell counts with chronic high volume diarrhoea had complete resolution of diarrhoea within two weeks of starting a gluten free diet, and her IEL count was normal in a biopsy specimen taken two months later. Another woman with recurrent severe aphthous ulceration had a trial of gluten free diet; she noticed some improvement but found the diet inconvenient and kept to it for only five weeks. Several months later, when studies of y/I IEL in a stored biopsy specimen were performed and counts were found to be high, she agreed to take 10 g additional gluten daily for a month and had another jejunal biopsy. Pathological examination showed subtotal villus atrophy. 
